Investing

Iovance Biotherapeutics : IOVA

IOVA

Stock Data

$2.20

$0.00 (0.00%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Iovance Biotherapeutics Inc is a pioneering biotech firm focused on developing innovative cell therapies for cancer treatment. Specializing in autologous tumor infiltrating lymphocyte technology, it offers solutions like Amtagvi for metastatic melanoma and Proleukin for renal cell carcinoma. The company is also advancing treatments for various cancers, including lung and gynecological cancers, through strategic partnerships with leading research institutions and biopharmaceutical companies. Originally Lion Biotechnologies, it rebranded to Iovance in 2017 and operates from San Carlos, California.

All Iovance Biotherapeutics Articles

6 Articles

Trey Thoelcke | Feb 27, 2024 at 8:45 AM EST

Stock Offerings Prompt Big Insider Buying

Public offerings of stock tempted some insider buying, and one insider stepped up to support a struggling online delivery service…

Chris Lange | Aug 27, 2021 at 8:45 AM EDT

Cathie Wood’s ARK Invest Sells Over 300,000 Shares of Iovance Bio

One of Cathie Wood's ARK Invest funds sold over 300,000 shares of cancer-focused biopharma startup Iovance Bio on August 26.

Chris Lange | Aug 26, 2021 at 8:45 AM EDT

Cathie Wood’s ARK Invest Sells Over 125,000 Shares of Iovance Bio

One of Cathie Wood's ARK Invest funds bought over 125,000 shares of Iovance Bio on August 25.

Chris Lange | May 21, 2021 at 10:05 AM EDT

Cathie Wood’s ARK Invest Buys Over 1 Million Shares of Iovance Bio

A couple of Cathie Wood's Ark Invest funds bought over 1 million shares of Iovance Bio on May 20.

Chris Lange | May 20, 2021 at 11:43 AM EDT

Merck, Micron, Nvidia, Target and More Thursday Afternoon Analyst Calls

24/7 Wall St. looks at some big analyst calls that we have seen so far on Thursday, including LendingTree, Merck,…

Jon C. Ogg | Mar 7, 2020 at 8:54 AM EST

10 Very Strong Stocks Thriving in a Very Crummy Stock Market

These 10 stocks have incredibly strong stock charts and strong performance despite the crummy market conditions that have been seen…